MedTrace Logo

Fish Oil and Cardiovascular Suboptimal Health

NCT02103517 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 422

Last updated 2017-01-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether omega-3 fatty acids supplementation are effective in the improvement of suboptimal health status and cardiovascular risk.

Conditions

  • Suboptimal Health Status

Interventions

DIETARY_SUPPLEMENT

Omega -3 fatty acids

Each subject assigned to active treatment group will receive 4 g/day capsule of omega-3 fatty acids.

DIETARY_SUPPLEMENT

Placebo: Corn oil

Each subject assigned to the control group will receive 4 g/day capsule of corn oil.

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Qiang Zeng, M.D · Chinese PLA General Hospital

  • Sheng-Yong Dong, M.D · Chinese PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02103517 on ClinicalTrials.gov